sofosbuvir 200 MG / velpatasvir 50 MG Oral Pellet [Epclusa]
RxNorm concept 2584201, branded drug (sbd). Prescribable name: Epclusa 200 MG / 50 MG Oral Pellet.
- RxCUI
- 2584201
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2584201 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Epclusa (sofosbuvir 200 MG / velpatasvir 50 MG) Oral Pellet
Related concepts
- sofosbuvir 200 MG (SCDC, consists of)
- velpatasvir 50 MG (SCDC, consists of)
- sofosbuvir 200 MG / velpatasvir 50 MG [Epclusa] (SBDC, consists of)
- Oral Pellet (DF, has dose form)
- Epclusa (BN, has ingredient)
- sofosbuvir 200 MG / velpatasvir 50 MG Oral Pellet (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2584201 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2584201 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2584201. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.